View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Durvalumab 1500 / Pemetrexed 500 / Cisplatin 75, Non-Small Cell Lung Cancer, neoadjuvant, cycle 1-4
Protocol-ID: 2492 V1.1 (Mini), DURV1500/PEME500/CISP75, NSCLC, neoadj., C1-4Indication(s)
- Lung Carcinoma, Non-Small Cell (non-squamous); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.12.2023